Pages that link to "Q48395727"
Jump to navigation
Jump to search
The following pages link to Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism (Q48395727):
Displaying 50 items.
- Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease (Q22242985) (← links)
- Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta (Q24677755) (← links)
- Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging (Q27020981) (← links)
- Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17 (Q27618950) (← links)
- Structural Basis for Stabilization of the Tau Pre-mRNA Splicing Regulatory Element by Novantrone (Mitoxantrone) (Q27655658) (← links)
- TDP-43 aggregation in neurodegeneration: are stress granules the key? (Q27692111) (← links)
- Tau physiology and pathomechanisms in frontotemporal lobar degeneration (Q28070250) (← links)
- Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease (Q28145739) (← links)
- Alpha-synuclein and tau: teammates in neurodegeneration? (Q28250508) (← links)
- The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. (Q31889013) (← links)
- Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy (Q33183514) (← links)
- Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland (Q33394006) (← links)
- Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies (Q33703950) (← links)
- Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics (Q33737396) (← links)
- Transgenic models of tauopathies and synucleinopathies (Q33750074) (← links)
- Neurodegenerative tauopathies: human disease and transgenic mouse models (Q33792966) (← links)
- Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature (Q33838058) (← links)
- Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease (Q33909959) (← links)
- Structure of tau protein and assembly into paired helical filaments (Q33971326) (← links)
- Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. (Q34132759) (← links)
- New insights into genetic and molecular mechanisms of brain degeneration in tauopathies (Q34156138) (← links)
- The role of tau (MAPT) in frontotemporal dementia and related tauopathies (Q34348115) (← links)
- Hereditary frontotemporal dementia caused by Tau gene mutations. (Q34627056) (← links)
- The role of tau in Alzheimer's disease (Q34777685) (← links)
- Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics (Q35538685) (← links)
- p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice (Q35624263) (← links)
- Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation (Q35748867) (← links)
- RNA Structures as Mediators of Neurological Diseases and as Drug Targets (Q35868044) (← links)
- The tangled biology of tau. (Q35979660) (← links)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases (Q36083108) (← links)
- Current strategies for the treatment of Alzheimer's disease and other tauopathies (Q36596669) (← links)
- SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (Q36847846) (← links)
- Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy (Q36966038) (← links)
- Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. (Q37200867) (← links)
- Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy (Q37663194) (← links)
- Molecular mechanisms of pathogenesis of Parkinson's disease. (Q37749063) (← links)
- Tauopathies: one disease or many? (Q37889469) (← links)
- Cell-to-cell communication and vascular dementia (Q37988907) (← links)
- Recent insights into the involvement of progranulin in frontotemporal dementia. (Q38015344) (← links)
- Cellular factors modulating the mechanism of tau protein aggregation (Q38350075) (← links)
- Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. (Q38435579) (← links)
- Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease. (Q38578250) (← links)
- Tau is not normally degraded by the proteasome (Q40441816) (← links)
- Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review (Q41704872) (← links)
- Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein (Q42491661) (← links)
- Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau. (Q42549383) (← links)
- Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein (Q42795195) (← links)
- The tauopathies: toward an experimental animal model (Q42850116) (← links)
- Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes (Q43559021) (← links)
- Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. (Q44894511) (← links)